In other words, prostate cancer incidence rates are higher in more developed countries because of the prostate cancer screening program, including the practice of PSA testing and subsequent biopsies, which induce a significant rise in reported prostate cancer incidence and mortality rates in these countries [28]. Here, KLK3 is linked to prostate carcinoma.